Literature DB >> 23867303

The microenvironment in classical Hodgkin lymphoma: an actively shaped and essential tumor component.

Yuxuan Liu1, Ahmad Sattarzadeh2, Arjan Diepstra3, Lydia Visser4, Anke van den Berg5.   

Abstract

Classical Hodgkin lymphoma (cHL) is characterized by a minority of tumor cells derived from germinal center B-cells and a vast majority of non-malignant reactive cells. The tumor cells show a loss of B-cell phenotype including lack of the B-cell receptor, which makes the tumor cells vulnerable to apoptosis. To overcome this threat, tumor cells and their precursors depend on anti-apoptotic and growth stimulating factors that are obtained via triggering of multiple membrane receptors. In addition, tumor cells shape the environment by producing a wide variety of chemokines and cytokines. These factors alter the composition of the microenvironment and modulate the nature and effectiveness of the infiltrating cells. The attracted cells enhance the pro-survival and growth stimulating signals for the tumor cells. To escape from an effective anti-tumor response tumor cells avoid recognition by T and NK cells, by downregulation of HLA molecules and modulating NK and T-cell receptors. In addition, the tumor cells produce immune suppressive cytokines that inhibit cytotoxic responses. In this review the relevance of the microenvironment in the pathogenesis of cHL will be discussed.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Hodgkin lymphoma; Immune escape; Immune shaping; Immune suppression; Microenvironment; Tumor cell survival

Mesh:

Substances:

Year:  2013        PMID: 23867303     DOI: 10.1016/j.semcancer.2013.07.002

Source DB:  PubMed          Journal:  Semin Cancer Biol        ISSN: 1044-579X            Impact factor:   15.707


  47 in total

1.  Rosetting T cells in Hodgkin lymphoma are activated by immunological synapse components HLA class II and CD58.

Authors:  Johanna Veldman; Lydia Visser; Magdalena Huberts-Kregel; Natasja Muller; Bouke Hepkema; Anke van den Berg; Arjan Diepstra
Journal:  Blood       Date:  2020-11-19       Impact factor: 22.113

Review 2.  Role of the tumor microenvironment in mature B-cell lymphoid malignancies.

Authors:  Nathan H Fowler; Chan Yoon Cheah; Randy D Gascoyne; John Gribben; Sattva S Neelapu; Paolo Ghia; Catherine Bollard; Stephen Ansell; Michael Curran; Wyndham H Wilson; Susan O'Brien; Cliona Grant; Richard Little; Thorsten Zenz; Loretta J Nastoupil; Kieron Dunleavy
Journal:  Haematologica       Date:  2016-05       Impact factor: 9.941

3.  Epigenetic loss of m1A RNA demethylase ALKBH3 in Hodgkin lymphoma targets collagen, conferring poor clinical outcome.

Authors:  Rosaura Esteve-Puig; Fina Climent; David Piñeyro; Eva Domingo-Domènech; Veronica Davalos; Maite Encuentra; Anna Rea; Nadia Espejo-Herrera; Marta Soler; Miguel Lopez; Vanessa Ortiz-Barahona; Gustavo Tapia; José-Tomás Navarro; Joan Cid; Lourdes Farré; Alberto Villanueva; Isolda Casanova; Ramon Mangues; Pablo Santamarina-Ojeda; Agustín F Fernández; Mario F Fraga; Miguel Angel Piris; Nitzan Kol; Chen Avrahami; Sharon Moshitch-Moshkovitz; Gideon Rechavi; Anna Sureda; Manel Esteller
Journal:  Blood       Date:  2021-02-18       Impact factor: 22.113

Review 4.  Targeting Immune System Alterations in Hodgkin Lymphoma.

Authors:  Natalie S Grover; Barbara Savoldo
Journal:  Curr Hematol Malig Rep       Date:  2017-08       Impact factor: 3.952

5.  Epstein-Barr virus recruits PDL1-positive cells at the microenvironment in pediatric Hodgkin lymphoma.

Authors:  O Jimenez; S Colli; M Garcia Lombardi; M V Preciado; E De Matteo; P Chabay
Journal:  Cancer Immunol Immunother       Date:  2020-11-12       Impact factor: 6.968

Review 6.  Hodgkin lymphoma.

Authors:  Joseph M Connors; Wendy Cozen; Christian Steidl; Antonino Carbone; Richard T Hoppe; Hans-Henning Flechtner; Nancy L Bartlett
Journal:  Nat Rev Dis Primers       Date:  2020-07-23       Impact factor: 52.329

Review 7.  Mechanisms of Immune Tolerance in Leukemia and Lymphoma.

Authors:  Emily K Curran; James Godfrey; Justin Kline
Journal:  Trends Immunol       Date:  2017-05-13       Impact factor: 16.687

Review 8.  Antibody-Drug Conjugates for the Treatment of Hematological Malignancies: A Comprehensive Review.

Authors:  Cédric Rossi; Marie-Lorraine Chrétien; René-Olivier Casasnovas
Journal:  Target Oncol       Date:  2018-06       Impact factor: 4.493

Review 9.  Mechanisms underlying the association between obesity and Hodgkin lymphoma.

Authors:  Andreia Matos; Joana Marinho-Dias; Sofia Ramalheira; Maria José Oliveira; Manuel Bicho; Ricardo Ribeiro
Journal:  Tumour Biol       Date:  2016-07-27

Review 10.  The immune microenvironment in Hodgkin lymphoma: T cells, B cells, and immune checkpoints.

Authors:  Santosha Vardhana; Anas Younes
Journal:  Haematologica       Date:  2016-07       Impact factor: 9.941

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.